CD44 and neoplasm: Despite this possible regulation of miR-4287 by AR, we observed a similar downregulation of EMT pathway mediators and stem cell marker CD44 in both AR negative (PC3) and AR positive (LNCaP) cell line emphasizing its tumor-suppressor role in prostate cancer.